SecBot SecBot
COURT-RULING ·Filed May 20, 2026

JNJ

Janssen
NEUTRAL
Impact 1/10
Horizonimmediate Processed6mo ago CourtCourt Ruling · courtlistener.com
Court ruling (appellate)
Actionable Insight • Neutral

This ruling has zero material impact on JNJ's operations, cash flows, or legal exposure. Xarelto product liability litigation has been ongoing for years with thousands of federal cases previously resolved or managed through MDL 2592. A single plaintiff's pro se dismissal on procedural grounds is not a read-through for broader Xarelto liability. No trader response warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$229.12
T+0 close · May 20, 2026 · via day close
Latest settled
+13.63%
T+60 · $260.34
Vs SPY
+8.89%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 20 $229.12entry
  2. T+1 · 6mo ago +1.07%α +0.88% · $231.58
  3. T+5 · 6mo ago +0.95%α −0.29% · $231.29
  4. T+20 · 5mo ago +2.22%α +2.26% · $234.20
  5. T+60 · 3mo ago +13.63%α +8.89% · $260.34
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

The Ninth Circuit affirmed the district court's dismissal of a product liability case against Janssen (JNJ subsidiary) and Bayer over Xarelto. The ruling was on procedural grounds, a child cannot bring loss-of-parental-consortium claims under California law, and a non-attorney guardian cannot prosecute pro se. The case was dismissed with no damages, no injunction, and no liability finding against JNJ. This is a complete win for JNJ on a routine, immaterial matter.

Court Ruling Details

Ruling Date
May 20, 2026
Court
United States Court of Appeals for the Ninth Circuit
Court Level
Appellate
Case Type
product liability
Ruling Type
final judgment
Outcome
WIN: ruling favors this company
Precedent Risk
LOW

Key Facts

  • Ninth Circuit affirmed dismissal of Hu v. Janssen over Xarelto injury claims
  • Loss of consortium claim dismissed with prejudice under California law (Borer v. American Airlines)
  • Remaining claims dismissed without prejudice because plaintiff, as non-attorney guardian, cannot litigate pro se
  • No damages, no injunction, no liability finding against Janssen or Bayer
  • Case is a routine procedural win for JNJ, no material financial exposure

Financial Impact

None, no damages awarded, no liability found, no ongoing exposure. Case was dismissed entirely on procedural grounds.

Risk Factors

  • Xarelto litigation broadly has been materially resolved, no systemic risk from this case
  • No appeal possible on the loss-of-consortium claim (affirmed); other claims dismissed without prejudice but plaintiff lacks counsel to refile

Market Snapshot

Price
$229.55
Volume
100
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
63% bullish (32 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-tus9vruz-JNJ

Track record

21 reports on JNJ

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +13.24% at T+60 after the May 13, 2026 report. 6 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today Institutional Cluster Mixed 3/10 Entry $289.75 Now $282.55 −2.48% settles Feb 12
  2. Nov 12, 20264d ago 144 Neutral 2/10 Entry $283.52 Now $282.55 −0.34% settles Feb 10
  3. Oct 13, 20264w ago 8-K Mixed 6/10 Entry $248.61 Now $282.55 +13.65% settles Jan 8
  4. Sep 30, 20266w ago Court Ruling Bullish 6/10 Entry $258.66 Now $282.55 +9.24% settles Dec 28
  5. Sep 24, 20267w ago Court Ruling Neutral 3/10 Entry $271.22 Now $282.55 +4.18% settles Dec 21
  6. Sep 9, 20269w ago Court Ruling Neutral 1/10 Entry $266.35 Now $282.55 +6.08% settles Dec 4
  7. Aug 18, 202612w ago Insider Cluster Neutral 2/10 Entry $273.41 to $283.52 Now $282.55 +3.34% ▲ +3.70% +5.25% vs SPY
  8. Aug 14, 202613w ago Insider Cluster Neutral 2/10 Entry $262.37 to $280.78 Now $282.55 +7.69% ▲ +7.02% +9.96% vs SPY
  9. Aug 7, 202614w ago Insider Cluster Neutral 3/10 Entry $261.81 to $266.17 Now $282.55 +7.92% ▲ +1.67% +4.08% vs SPY
  10. Aug 7, 202614w ago Court Ruling Bearish 4/10 Entry $261.81 to $266.17 Now $282.55 −7.92% ▼ −1.67% −4.08% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens Wed (10h 49m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · courtlistener.com Report published May 20, 2026